Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc
 
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 28,
Hindmarsh,
South Australia 5007

Office:
Suite 506,
North Terrace House,
19 North Terrace,
Hackney, SA, 5069


Phone:
1300 128 339

Office Hours:
Wednesdays, 11am-3pm

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 242KB)
Why become a member?

Anti-seizure medication shows promise in relieving Fibromyalgia symptoms

Sunday 15 July 2012

 

From Medify:

 

WomanAnti-Seizure Medication Shows Promise in Relieving Fibromyalgia Symptoms

By Kristan Binczewski
06 Jul 2012

The Drug Clonazepam, Typically Used to Control Seizures and Panic Attacks, May Help Relieve Pain for Fibromyalgia Patients

Clonazepam is a long-acting benzodiazepine with muscle relaxant and anticonvulsant effects. Typically used to control seizures and panic attacks, as well as anxiety and depression, the drug has shown promise in treating the pain that comes with fibromyalgia.

Researchers at Oregon Health Sciences University (OHSU) examined responses to a survey conducted by the National Fibromyalgia Association (NFA). Over 2,500 people responded, most of whom had suffered from fibromyalgia for four or more years. Among the medications respondents self-reported as most effective for relieving fibromyalgia was clonazepam.

However, an Oxford University study found no evidence to support the use of clonazepam in chronic neuropathic pain or fibromyalgia. In this study, experts planned to extract clonazepam research from a database of clinical trials. The research needed to include randomized, double-blind studies of eight weeks or longer that compared clonazepam with placebo or another active treatment in fighting the chronic pain associated with fibromyalgia. Data that met the inclusion criteria could not be found.

Clonazepam tends to cause more side effects than other benzodiazepines, including, cough, dizziness, drowsiness, dry mouth, headaches, loss of coordination, nausea and constipation. More research is needed to determine whether the drug can be used as a viable option for treating fibromyalgia pain and whether its side effects are worth the risk.

Medify, which has over 2,145 research abstracts on fibromyalgia alone, is on a mission to provide patients and their loved ones access to the best information online about their medical condition.

Learn More About Clonazepam

 

The above originally appeared here.

 


Arrow right

More Fibromyalgia News

 


 

blog comments powered by Disqus
Previous Previous Page